Skip to content

Application value of artificial intelligence in predicting hematoma changes in patients with hypertensive intracerebral hemorrhage: a prospective, observational real world study

Application value of artificial intelligence in predicting hematoma changes in patients with hypertensive intracerebral hemorrhage: a prospective, observational real world study

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000036008
Enrollment
Unknown
Registered
2020-08-21
Start date
2020-10-01
Completion date
Unknown
Last updated
2020-08-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

hypertensive intracerebral hemorrhage

Interventions

Gold Standard:Clinical outcome
Index test:condition&#32
pre-judgment&#32
system&#32
based&#32
on&#32
imagemics

Sponsors

Huashan Hospital, Fudan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
15 Years to 70 Years

Inclusion criteria

Inclusion criteria: Patients with hypertensive intracerebral hemorrhage within 6 hours of onset; age > 14 years old but less than 70 years old

Exclusion criteria

Exclusion criteria: Patients with secondary cerebral hemorrhage Patients need immediate craniotomy to remove hematoma

Design outcomes

Primary

MeasureTime frame
Progressive cerebral hemorrhage;

Countries

China

Contacts

Public ContactJian Yu

Huashan Hospital, Fudan University

lance2002@hotmail.com+86 13918076825

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026